Current absence of pyrimethamine resistance of Plasmodium falciparum in Madagascar

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 5, 2002, Pages 557-559

  Randrianarivelojosia, Milijaona ^a   Ariey, Frédéric ^a   Raharimalala, Lucie A ^a   Parzy, Daniel ^b   Rogier, Christophe ^b   Jambou, Ronan ^a,c  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

Chemotherapy; dhfr; Madagascar; Malaria; Plasmodium falciparum; Pyrimethamine sensitivity

Indexed keywords

ANTIMALARIAL AGENT; ASPARAGINE; PYRIMETHAMINE; RESTRICTION ENDONUCLEASE; THREONINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CODON; CONTROLLED STUDY; GENE AMPLIFICATION; GENETIC CODE; GEOGRAPHIC DISTRIBUTION; IC 50; IN VITRO STUDY; ISOLATION PROCEDURE; MADAGASCAR; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SEASHORE;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036759061     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90441-4     Document Type: Article

References (18)

1. Aronsson, B., Bengtsson, E., Björkman, A., Pehrson P. O., Rombo, L. & Wahlgren, M. (1981). Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Annals of Tropical Medicine and Parasitology, 75, 367-373.
2. Basco, L. K. & Le Bras, J. (1997). In vitro sensitivity of Plasmodium falciparum to antifolinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains. Bulletin de la Société de Pathologie Exotique, 90, 90-93.
3. Basco, L. K. & Ringwald, P. (1999). Molecular epidemiology of malaria in Yaoundé, Cameroon IV. Evolution of pyrimethamine resistance between 1994 and 1998. American Journal of Tropical Medicine and Hygiene, 61, 802-806.
4. Basco, L. K., de Péoulas, P. E., Le Bras, J. & Wilson, C. M. (1996). Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Experimental Parasitology, 82, 97-103.
5. Brooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. G. & Hyde, J. E. (1994). Sequence variation of the hydroxymethyldihydropterin pyro-phosphokinase:dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. European Journal of Biochemistry, 2, 397-405.
6. Deloron, P., Le Bras, J., Ramanamirija, J. A. & Coulanges, P. (1985). Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Annals of Tropical Medicine and Parasitology, 79, 357-365.
7. Hyde, J. E. (1990) The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacology and Therapeutics, 48, 45-59.
8. Milijaona, R., Raharimalala, L., Parzy, D., Roux, J. F. & Jambou, R. (1999). DHFR and Plasmodium falciparum resistance to antifolates: search for other mutations in the Indian Ocean region. Bulletin de la Société de Pathologie Exotique, 92, 282.
9. Parzy, D., Doerig, C., Pradines, B., Rico, A., Fusai, T. & Doury, J.-C. (1997). Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing. American Journal of Tropical Medicine and Hygiene, 57, 646-650.
10. Peterson, D. S., Milhous, W. K. & Wellems, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the USA, 87, 3018-3022.
11. Plowe, C. V., Kublin, J. G. & Doumbo, O. K. (1998). Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resistance Updates, 1, 389-396.
12. Raharimalala, L., Ramambanirina, L., Rason, M. A., Ranaivo, L., Lepers, J. P. & Jambou, R. (1995). Heterogeneity of transmission and chemoresistance of Plasmodium falciparum to antimalarials in Madagascar: a relationship to watch. Médecine Tropicale, 55, supplement, 84-87.
13. Raharimalala, A. L., Randrianarivelojosia, M., Randriamanantena, A., Ranarivelo, L. A., Jaureguiberry, S., Rason, M. A., Rakotomalala, E. & Ariey, F. (2000). Chemosusceptibility of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro study. Archives de l'Institut Pasteur de Madagascar, 66, 26-31.
14. Randrianarivelojosia, M., Raharimalala, L., Randriamanantena, A. & Jambou, R. (2000). Drug resistance of Plasmodium falciparum in coastal regions of Madagascar. Médecine Tropicale, 60, 243-249.
15. Randrianarivelojosia, M., Raharimalala, L. A., Randrianasolo, L., Ratsimbasoa, A., Rason, M. A., Ariey, F. & Jambou, R. (2001). Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro. Annals of Tropical Medicine and Parasitology, 1, 237-243.
16. Triglia, T. & Cowman, A. F. (1994). Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the USA, 91, 7149-7153.
17. Wang, P., Read, M., Sims, P. F. & Hyde, J. E. (1997). Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in hydropteroate synthase and an additional factor associated with folate utilization. Molecular Microbiology, 94, 979-986.
18. WHO (1990). Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, supplement 2.